Pfizer Inc. PFE
$26.80
+1.86%
at last close
Analyst Consensus
- Consensus Rating
- Hold (5 Buy · 8 Hold · 1 Sell)
- Average Price Target
- $28.79
- Implied Upside
- +7.4%
- Price Target Range
- $25.00 – $35.00
- Analysts (12 mo)
- 14
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-08-07 | GuggenheimVamil Divan |
Maintains | Buy | $35 → $31 |
| 2026-07-13 | BMO CapitalEvan David Seigerman |
Maintains | Outperform | $34 → $30 |
| 2026-07-13 | GuggenheimVamil Divan |
Maintains | Buy | $36 → $35 |
| 2026-07-10 | B of A SecuritiesJason Gerberry |
Maintains | Neutral | $27 → $26 |
| 2026-07-08 | JP MorganChris Schott |
Maintains | Neutral | $30 → $28 |
| 2026-07-06 | Cantor FitzgeraldCarter Gould |
Reiterates | Neutral | $27 |
| 2026-07-06 | HSBCRajesh Kumar |
Downgrades | Buy → Hold | $32 → $28 |
| 2026-06-10 | RBC CapitalTrung Huynh |
Upgrades | Underperform → Sector perform | $25 |
| 2026-04-29 | CitigroupGeoff Meacham |
Maintains | Neutral | $26 → $27 |
| 2026-04-20 | RBC CapitalTrung Huynh |
Reiterates | Underperform | $25 |
| 2026-04-16 | CICCJin Zhang |
Initiates coverage on | Outperform | $33 |
| 2026-04-13 | UBSMichael Yee |
Maintains | Neutral | $25 → $27 |
| 2026-04-10 | Morgan StanleyTerence Flynn |
Maintains | Equal-weight | $27 → $28 |
| 2026-04-09 | B of A SecuritiesJason Gerberry |
Maintains | Neutral | $27 → $26 |
| 2026-03-24 | GuggenheimVamil Divan |
Maintains | Buy | $35 → $36 |
| 2026-03-17 | HSBCRajesh Kumar |
Maintains | Buy | $29 → $32 |
| 2026-03-02 | Argus ResearchDavid Toung |
Upgrades | Hold → Buy | $35 |
| 2026-02-25 | RBC CapitalTrung Huynh |
Initiates coverage on | Underperform | $25 |
| 2026-02-20 | BarclaysEmily Field |
Initiates coverage on | Underweight | $25 |
| 2026-02-09 | Freedom BrokerIlya Zubkov |
Maintains | Buy | $35 → $33 |
| 2026-02-04 | Cantor FitzgeraldCarter Gould |
Reiterates | Neutral | $27 |
| 2026-01-27 | Cantor FitzgeraldCarter Gould |
Maintains | Neutral | $24 → $27 |
| 2026-01-07 | UBSMichael Yee |
Assumes | Neutral | $25 |
| 2025-12-17 | Morgan StanleyTerence Flynn |
Maintains | Equal-weight | $28 → $27 |
| 2025-12-15 | B of A SecuritiesJason Gerberry |
Maintains | Neutral | $29 → $28 |
| 2025-12-12 | Morgan StanleyTerence Flynn |
Maintains | Equal-weight | $32 → $28 |
| 2025-12-02 | CitigroupGeoff Meacham |
Reinstates | Neutral | $26 |
| 2025-11-24 | GuggenheimVamil Divan |
Maintains | Buy | $33 → $35 |
| 2025-10-10 | Morgan StanleyTerence Flynn |
Maintains | Equal-weight | $33 → $32 |
| 2025-10-03 | B of A SecuritiesTim Anderson |
Maintains | Neutral | $28 → $30 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $26.80
- Market Cap
- $149.96 billion
- 52-Week Range
- $23.11 – $28.75
- Average Volume
- 41.37 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.